CS
Chloé Steen
Research areas: Medicine · Pathology and Forensic Medicine · Lymphoma Diagnosis and Treatment · Cancer Immunotherapy and Biomarkers · Single-cell and spatial transcriptomics
0000-0001-7290-7128
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (21)
- Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma Save
- High-resolution alignment of single-cell and spatial transcriptomes with CytoSPACE Save
- Identification of a minority population of LMO2 + breast cancer cells that integrate into the vasculature and initiate metastasis Save
- Robust alignment of single-cell and spatial transcriptomes with CytoSPACE Save
- Inferring gene expression from cell-free DNA fragmentation profiles Save
- T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma Save
- Atlas of clinically distinct cell states and ecosystems across human solid tumors. Save
- The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma. Save
- LMO2 is critical for early metastatic events in breast cancer Save
- Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition Save
- Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series Save
- Profiling Cell Type Abundance and Expression in Bulk Tissues with CIBERSORTx. Save
- Computational approaches for characterizing the tumor immune microenvironment. Save
- Determining cell type abundance and expression from bulk tissues with digital cytometry. Save
- A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy. Save
- Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-Up. Save
- Artesunate shows potent anti-tumor activity in B-cell lymphoma. Save
- T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling. Save
- Favorable lifestyle before diagnosis associated with lower risk of screen-detected advanced colorectal neoplasia. Save
- ALIX and ESCRT-III coordinately control cytokinetic abscission during germline stem cell division in vivo. Save